Jeffrey Wendel, MBA, President and Chief Executive Officer
Jeffrey Wendel has over 20 years of executive leadership experience providing consulting and systems integration services to Global 500 companies in the pharmaceutical, financial services and high technology industries. Since joining Chesapeake IRB in 2006, he led the implementation of the cloud-based IRB management platform CIRBI. Prior to joining Chesapeake, Wendel served as president of a systems integration group following a successful IPO. He has also led an international business unit focused on simulation software modeling and established a government services division supporting U.S. and international agencies.
Wendel earned a bachelor’s degree in systems engineering from the U.S. Naval Academy and an MBA from Loyola College. He has been a member of the AAHRPP Board of Directors since 2010, serving as chairman since January 2014.
Scott Uebele, MBA, Chief Financial Officer
Scott Uebele brings nearly a decade of executive-level financial leadership and M&A experience within the clinical research space. Uebele directs the financial, legal and contracts activities of Chesapeake IRB. Previously, he served as the global vice president of finance for Research Pharmaceutical Services (RPS), a global clinical research organization now part of PRA Health Sciences, with executive oversight of the tax, compliance, analysis and reporting functions including personnel and deliverables in 68 countries. He has also served in multiple finance roles for both mid-cap and Global 500 organizations.
Uebele earned his bachelor’s in economics from Bucknell University and his MBA in finance from Seton Hall University, where he was awarded the Robert Trocolli Business Policy Award.
Lauri Carlile, MS, CIP, Executive Director
Lauri Carlile has over 20 years of experience in preclinical and clinical research. Carlile directs Chesapeake IRB’s operations including regulatory compliance, client services, IRB Management, training and AAHRPP and AAHRPP accreditation processes. Previously, Carlile served in various quality and compliance roles supporting the Human Research Protection Program as well as an administrative chair for Harvard/Partners HealthCare System in Boston.
Carlile is a frequent speaker on human research protections and is a member of Public Responsibility in Medicine & Research (PRIM&R), Regulatory Affairs Professionals Society (RAPS), Association of Clinical Research Professionals (ACRP) and is a certified IRB professional (CIP).
Carlile holds a bachelor’s degree in biological sciences from the University of Maryland, Baltimore County (UMBC) and a master’s degree in clinical investigation from MGH Institute of Health Professions where she received the first award for academic excellence in clinical investigation.
Nitin Uplekar, MS, PMP, PE, Chief Information Officer
Nitin Uplekar has over 35 years of executive leadership experience providing consulting and systems integration services to Fortune 500 companies in the health care, telecommunications and high technology industries, and to federal agencies. Uplekar directs the information technology, strategy and performance management functions at Chesapeake IRB, including our cloud-based IRB management platform. He has led several high visibility regulatory implementations requiring highly scalable, high-availability hosted systems with performance-intensive applications while at Northrop Grumman and in support of the Center for Medicare and Medicaid Services and the Social Security Administration. Uplekar has successfully formulated and led complex system integration projects with quantifiable ROI during his tenure at PowerVision Corporation, RWD Technologies, Inc., IBM and Nuclear Power Plants Simulation industry.
Uplekar earned a Bachelor of Technology in mechanical engineering from the Indian Institute of Technology Bombay, a master’s in mechanical engineering from Syracuse University and a master’s in computer science from Johns Hopkins University.
Randall Hein, Senior Vice President, Sales & Marketing
Randall Hein has more than 20 years of operational, sales and consulting experience in the life sciences industry. With a significant background in Phase I-III drug development, Hein has led numerous clinical pharmacology units/sites supporting patient and healthy volunteer studies. He has overseen international operations for scientific and data services. Hein has developed and managed multiple sales and marketing teams providing services to the pharmaceutical and biotechnology industry and has successfully launched new therapeutic service lines, novel pharmaceutics technology and medical informatics services.
Prior to joining Chesapeake IRB, Hein served as senior vice president, clinical research services, for PRA Health Sciences. He has served in multiple senior sales and operations roles at industry-leading clinical research organizations.
Hein earned his bachelor’s in social science with high distinction from the University of Nebraska-Lincoln and participates actively in many industry associations.
Board of Directors – Industry Members
Pat Donnelly, MBA, Chairman, Board of Directors
Pat Donnelly, who has more than 35 years of industry experience, was most recently chairman and chief executive officer of Aptiv Solutions, a global pharmaceutical development services business he founded, which was acquired by ICON in May 2014. Prior to that, Donnelly served as president and chief executive officer and was one of the founders of PRA International (now PRA Health Sciences). He was instrumental in building PRA from a small regional contract research organization to a global industry leader.
Donnelly received his bachelor’s degree from the University of Missouri in 1980 and an MBA from The Pennsylvania State University in 1984.
In addition to serving as current board chairman for Chesapeake IRB, he is a board director at Pro Pharma, MedGenesis Therapeutix, Phase 5 LLC, Celerion and Rediscovery Life Sciences.
John Potthoff, PhD, Member, Board of Directors
John Potthoff, PhD, is a respected industry veteran with more than 24 years in the clinical research services industry and has directed major business growth throughout his career. Beginning with seven years in executive roles at PPD, he left to become the founder and chief executive officer of Tanistry, Inc., a contract research organization focused on the central nervous system. After selling Tanistry to INC Research in 2001, he joined the INC Research organization, eventually becoming chief operating officer. Following his success at INC Research, Potthoff assumed the position of CEO at Theorem Clinical Research in 2011. After Theorem was sold to Chiltern in 2015, Potthoff remained with the organization as a board member. Currently, Potthoff is the co-founder and CEO of Elligo Health Research, Inc.